Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-16

A sequential high throughput ion channel screening system for drug discovery in neurological and psychiatric disorders

Objective

ION is a co-operative research proposal for the development of an innovative system capable of an efficient screening of candidate drugs on a wide set of targets (ion channels) involved in important neurological and psychiatric disorders, e.g. depression, Parkinson, epilepsy, migraine and pain. The proposers are a group of SMEs which includes technological companies and end users in the pharmaceutical sector. The RTD partners are required to provide the knowledge and the research capabilities to address the selection and optimization of the cellular targets and to validate the outcomes of the system in relation to the results of in vivo models of the pathologies of interest. However, an important contribution of the RTD partners will be to design a suite of innovative software agents for data analysis and experimental planning. The role of these agents is essential to achieve real high screening throughputs. The ION project will optimize the performance of a sequence of screening experiments instead of focusing on the execution of a single experiment. With respect to the current state of the art, the proposed development will introduce two important innovations. First, easy access to a large set of targets and to an efficient drug discovery process, exploiting a well designed and implemented library of starting molecular structures. Second, it will develop innovatively the analysis of the output and enable future experiments to be planned more effectively by introducing intelligent software agents interpreting the outcome of an experiment and planning the next experiment of a drug discovery screening sequence. The proposers estimate a large market in the EU, USA and Japan for their future products due to the expanding pharmaceutical research in the considered disorders which are still an unmet medical need. The proposing SMEs intend to present a common business plan in order to exploit the expected results worldwide.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

Cooperative - SMEs-Co-operative research contracts

Coordinator

NEWRON PHARMACEUTICALS SPA
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (8)

My booklet 0 0